• Aucun résultat trouvé

'·DSUqVOHVFRPPXQLFDWLRQVGH3&RVWD HW-(7HUULHU -1&RUQX 3UHPLHUWUDLWHPHQWWRSLTXHGHODG\VIRQFWLRQpUHFWLOHXQQRXYHDXSDUDGLJPH

N/A
N/A
Info
Télécharger
Protected

Academic year: 2022

Partager "'·DSUqVOHVFRPPXQLFDWLRQVGH3&RVWD HW-(7HUULHU -1&RUQX 3UHPLHUWUDLWHPHQWWRSLTXHGHODG\VIRQFWLRQpUHFWLOHXQQRXYHDXSDUDGLJPH"

Copied!
3
0
0

Chargement.... (Voir le texte intégral maintenant)

Texte intégral

(1)

!"# #

108e Congrès de l’Association Française d’Urologie (AFU) Dysfonction érectile et autres temps forts

85145

Volume 25 - Avril 2015 – Hors série 2

ISSN 1166- 7087

Numéro réalisé avec le soutien institutionnel du laboratoire Majorelle

,QWURGXFWLRQ

%!&'("# (" ) "&*+",* "'#- "

.#" *"+ )'"! " " * "

-"#! " '(/(# )+ " 0"

"""! 1*! 2+- ." 3 ! ++"*( % (**!"(" '"

#""! !"# "! 4 '5(("#! "" * "+/*

(- '* ! (*+*#/3" ! +/

+/! "# ! "&+ !46 (""( ! +"! 7 + !" ." +33 * " +(

+ '* "+- ( ! "" * "! 4'5(

# (" '' "8- "(/ 9! +" """#+

)1VHULH]YRXVVXVFHSWLEOHG·XWLOLVHUXQQRXYHDXWUDLWHPHQW XQHFUqPHTXHO·RQDSSOLTXHGLUHFWHPHQWjO·H[WUpPLWpGX SpQLVjODSODFHGHYRWUHWUDLWHPHQWDFWXHO"2:!

+" "#+! "7" ";" "" * "

"+- +++("( #( ** "#"#*+"

"+"("" " " +" " ! 4 "/#+ "- ! "" * "! )

3ULQFLSHWKpUDSHXWLTXH

<4"!4*# !4+"!'* ! &"/ ! +"! " =( + ++#"#

+ * """ ."! ( *( *

"8 !"""# "! ))<>7 (! "(** ((##" ! !''"

! *- %4++("!+!"!+"!" ! 4" !*#" " !4 +##""

! *#( !4+"! (+ + . "

(+ ( . ; "*" . ((*""

" (**!# % +!" "+# "#'* !4 (* ?( "" #- " + * """

*! !4!*""!"" * "' (/"

+3"#! "" * "! )

(IÀFDFLWp

%(* !4+"! ++("( #"#" "#

!4 "/#+ "- ! +/ @ + * """

!4# '5(("# " "#( AB #"!

*"( "- !*# (*+" +"!

" @ C (" +( 3 " #"# * # (/ 9 ! +" " "" " ! ) "" DE +" " AB % (" !4 '5(("# (/ + ( #"! #" " ! (" 36 ("'""! ( !#A=F*OREDO

$VVHVVPHQW4XHVWLRQV<<G,QWHUQDWLRQDO,QGH[RI(UHFWLOH )XQFWLRQ VH[XDOHQFRXQWHUSURÀOHB % !# !

#"! " " " * % (" !4(

H" ( +!"

$GUHVVHHPDLO6(I/"*'JK7

3UHPLHUWUDLWHPHQWWRSLTXHGHODG\VIRQFWLRQ pUHFWLOHXQQRXYHDXSDUDGLJPH

-1&RUQX

D

'·DSUqVOHVFRPPXQLFDWLRQVGH3&RVWD

E

HW-(7HUULHU

F

D6HUYLFHG·8URORJLH+{SLWDO7HQRQ8QLYHUVLWp3DULV$3+3 UXHGHOD&KLQH3DULV

E6HUYLFHG·8URORJLH$QGURORJLH&+58GH1vPHV+{SLWDO8QLYHUVLWDLUH&DUpPHDX SODFHGX3U'HEUp1vPHVFHGH[

F6HUYLFHG·8URORJLH&+/\RQ6XGFKHPLQGX*UDQG5HYR\HW3LHUUH%pQLWH

(2)

* "" * ""+- ! !&'("# (" L +!* D

! ( #"! "+ *! !(* " 4 '5(("#!

(* !4+"!(/ 9! +" "+# ""+5

!#'3 )# "O( "!'5( 8""

; + * #"! (/ 9E+" "+# "" )

# <<G*& ! 3 8PEQD+ *! * ""

#! ( '5(("#!+!" (* ""!

DD+"!4<<G+++"+( 3 " *#"

! 4# ("(/ 9D:! +" "! ! C " @ : ! ! @ C G AB =3 * "

(*+3 84 '' "! <)! " ++"

#""!"" * "#" " ( "

) ." #"! !4 "##4 '5(("#

!+!"(/ 9! +" "(!##(** +# ""

)!'5( 8"" "( AB7 ! .#"! ! +/ @" '' "#"#(!" (/ 9! +" "+","

R#!"P@: " )! ++! * +# "" + (*3!"# /&+ "

E : # * " (!( P : !3"

:!#+ P:(( ! +"" : " *0* + ( " /&+!* : AB ) ( "" ++"""# + !" * .""

*#" 5(" ! ( <<G (/ 9 + ! :! +" """# (C "@C!4+"

!7 #"" ("" # -4*+

" (*+ ." *3 "*3 - ( .3" ( "" * "+/*(- (" * "!+3

% & + ! ( "" ++"+","

/#"# *" "! #""+3"!+

""(- (!## (** !#(" "#(#! "

! (( ! +"" ! (( "/#( ("

! "*"* !3! +"/ !3#"- ##

( ! +" "#+! !#5G

; !4 "*"( "- ! +/

@+ *! ("" * ""! 4 '5(("#!

"" * "! " *+ ( *#"!(

<<G! +! +++"!#3"! 4#"! A@B

7ROpUDQFH

% +5! "#( ! (* !4+"!#"##"!#

(! #"! ! +/ @-"+ *!436 ("

+ "&+ !4 '' " (! AB '' "

(# * "!#3 *+"3 "" * "

4#"#* #! ( !( % '' "!#

3 #" "(. (EP:! (! "

! 3S +# !4" "## 8*!## +"

!4++("+"#* "#"'D:!4#&"/*

+# P:! "3 +# :! " :!

&(+ ":!4/&+" T""# * "(

#! ++* ) '' " (! (/ 9+"

#" "36 ("#!D:! (+(+ * "

'* !4 '' " (! (.

% (#- ( ! ( '' " (! #" "

'3 ( 4" "# 40" ! "" * " -

!@:! (( - *3"3 '# .!#

++"# + " "" * "+/*(-

!+3 7 !# #" "(5*# ! #"!

" ! +/ @ (*! A@B

9HUVXQHSRWHQWLHOOHDOWHUQDWLYH WKpUDSHXWLTXH"

% "" * "+(* !4+"!!4+ #"!

!+3 "!( +"+* "" !'"!

'5(("#+++"+( 3 "! ++ ** "

.( "+5! "#( ) ("#- #""

(4 " * +" " +(*3""

)< ." ( + !"! *3 ""8

* ++#( L

U # ("! +" "#""8*0* ! 3##5(

* .! ( "" * "?

U +3"#!4(" (!4" "" * "!

)?

U +( ! ( *#!(* "!43 !#( !

"" * "?

U #""! 4 8" *

&RQFOXVLRQ

% "" * ""+- ! )+++("( !4 (* !4+"! " "/#+ "- +* ""

++ ** " '5(( "S ) +*+ ""

+"(5* ! !# - , -4 "++ # 86 ( "" +" ! 4 "/#+ "- )LJXUH'5(("#!"" * "! (! )#

$V"! 4<<GYV+( 3?%V"!( =F!

@+ +( 3"" * "8C"" * "8@C 8

3,82 A

B

Variation score IIEF-EFScores GAQ

26 %

Placebo Crème alprostadil 200 μg vs placebo

Crème alprostadil 200 μg vs placebo

Crème alprostadil 300 μg vs placebo

Crème alprostadil 300 μg vs placebo

76 % 83 %

6,77

p < 0,001

p < 0,001

p < 0,001 1

0,9 0,8 0,7 0,6 0,5 0,4 0,3 0,2 0,1 0 7 6 5 4 3 2 1 0

(3)

JK7 "

/LHQVG·LQWpUrWV

JK7L(- L -"#!4 ""

+(+ (!" .+#* "" +(+

=W?<" "+(" L(""#! ( 7+"59 X(/Y (!"" !/*

X(*+"3 ;W Z !?7'# ( L""

-"#!4!" '! !#+( * " "!4/#3 * "

+ (/ + " + ) X!

=W? X > " ! "# TZ !

; " G;

5pIpUHQFHV

AB !*K"/>[ J%" " !&'+

"!"+(( *'"/ " "* "' (" !&'("

D@+" ";&?L@P

AB !*K"/ > " ! 7 * & K [ J

> Y / '5((& ! ' "& ' "+( +"!

( *+. )'"/ " "* "' (" !&'("L

"\+/ "! *!"*! " ! )<"J

<*+"Y @?LD

A@B Y &5" ]/ &K [ J" ! 7%" **"( " "!&'"/ ' "&! '5((&

' "+( +"! ( * * +" " \"/ ("

!&'("J . !P?L@E

)LJXUH'5(("#!"" * "!! + +"( 4#" ! )"! 4<<G+++"+( 3

$7( ! +"" Q^@?%7( ! ( ("?& *"* !3?'K +"/ !3#"- ## ? (" "#+! !#5

8

4,4

p < 0,004

5,2 7

6 5 4 3

1 2

0

A

Crème alprostadil

200 μg

Crème alprostadil

300 μg

7,5

6,6 12

10

8

6

4

2

0

B

Crème alprostadil

200 μg

Crème alprostadil

300 μg

2,7 2,6

5

4

2

1

0 3 4,5

2,5

0,5 1,5 3,5

E

Crème alprostadil

200 μg

Crème alprostadil

300 μg p < 0,02

p = 0,0951 2,9

2,5

2

1

0 3 2,5

0,5 1,5 3,5

C

Crème alprostadil

200 μg

Crème alprostadil

300 μg

4,3 6,2

7 6 5 4 3

1 2

0

D

Crème alprostadil

200 μg

Crème alprostadil

300 μg

Références

Télécharger maintenant ( PDF - 3 Page - 472.83 KB )

Documents relatifs

Fruuhfwlrq gh o*h{dphq gh gìfhpeuh 5334 H{huflfh 4 = Lqwìjudohv gh Ohehvjxh hw vìulh1 4d1G*dsuëv

[r]

*$PDUHQFR HW-)+HUPLHX  93Kp 5pGLJpSDU-1&RUQX '·DSUqVOHVFRPPXQLFDWLRQVGH-1&RUQX 1RXYHDXWpVFRQFHUQDQWO·K\SHUDFWLYLWpYpVLFDOHpSLGpPLRORJLHSK\VLRSDWKRORJLHHWSULVHHQFKDUJHWKpUDSHXWLTXH

[r]

5pGLJpSDU-1&RUQX HW)+DDE '·DSUqVOHVFRPPXQLFDWLRQVGH*$PDUHQFR ;*DPp 7UDLWHPHQWVSKDUPDFRORJLTXHVGHO·K\SHUDFWLYLWpYpVLFDOHG·DXMRXUG·KXLHWGHGHPDLQ

[r]

5pGLJpSDU)$XGHQHW *&UHKDQJH 

3. Altère la liaison RA-ADN, bloquant la machinerie

)/H%UHWRQ 6\QGURPHGHODTXHXHGHFKHYDO

&amp;RORSODVW :HOOVSHFW $VWHOODV $OOHUJDQ ,QWHUYHQWLRQV SRQFWXHOOHV UDSSRUWV G·H[SHUWLVH &amp;RORSODVW :HOOVSHFW ,QWHUYHQWLRQV SRQFWXHOOHV DFWLYLWpV GH FRQVHLO

;*DPp '\VIRQFWLRQpUHFWLOH

,OQ·DDXFXQDQWpFpGHQWHQGHKRUVG·XQDFFLGHQWGHODYRLH SXEOLTXHVXUYHQXPRLVDXSDUDYDQWDXFRXUVGXTXHOLODpWp

6%DUW &RPSOLFDWLRQVGHODVRQGHjGHPHXUH

/·pYDOXDWLRQGXIRQFWLRQQHPHQWGXEDVDSSDUHLOXULQDLUH SHXWV·HIIHFWXHUGHODPDQLqUHVXLYDQWHLOHVWLPSpUDWLI

'·DSUqVOHVFRPPXQLFDWLRQVGHV3URIHVVHXUV%0DODYDXG 6&XOLQH 0=HUELE 7%HVVHGH /HFDQFHUGHODSURVWDWHUpVLVWDQWjODFDVWUDWLRQ &35& PpWDVWDWLTXHDXFRQJUqVGHO·$)8

[r]